Skip to content
← Full study record

NCT00002874 · BASELINE

Baseline characteristics

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy · Source last updated 2022-06-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      376
    2. group Id
      BG001
      value
      384
    3. group Id
      BG002
      value
      760
    units
    Participants
groups
  1. description
    Radiation therapy (64.8 Gy) + bicalutamide (150 mg daily 2 years)
    id
    BG000
    title
    Bicalutamide
  2. description
    Radiation therapy (64.8 Gy) + placebo (daily 2 years)
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          45
          upper Limit
          81
          value
          65
        2. group Id
          BG001
          lower Limit
          40
          upper Limit
          83
          value
          65
        3. group Id
          BG002
          lower Limit
          40
          upper Limit
          83
          value
          65
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          376
        2. group Id
          BG001
          value
          384
        3. group Id
          BG002
          value
          760
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible patients who have not withdrawn
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      376
    2. group Id
      BG001
      value
      384
    3. group Id
      BG002
      value
      760
    units
    Participants
groups
  1. description
    Radiation therapy (64.8 Gy) + bicalutamide (150 mg daily 2 years)
    id
    BG000
    title
    Bicalutamide
  2. description
    Radiation therapy (64.8 Gy) + placebo (daily 2 years)
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          45
          upper Limit
          81
          value
          65
        2. group Id
          BG001
          lower Limit
          40
          upper Limit
          83
          value
          65
        3. group Id
          BG002
          lower Limit
          40
          upper Limit
          83
          value
          65
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          376
        2. group Id
          BG001
          value
          384
        3. group Id
          BG002
          value
          760
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible patients who have not withdrawn

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice